Cprx financials
WebApr 12, 2024 · Catalyst Pharmaceuticals - CPRX News Today $17.38 +0.45 (+2.66%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $16.83 $17.41 50-Day Range $14.34 $17.38 52-Week Range $6.15 $22.11 Volume 1.94 million shs Average Volume 1.99 million shs Market Capitalization $1.84 billion P/E Ratio 23.49 Dividend Yield N/A Price Target … WebCatalyst Pharmaceuticals, Inc. (CPRX) Income Statement - Yahoo Finance U.S. markets closed S&P 500 +58.48(+1.44%) Dow 30 +415.12(+1.26%) Nasdaq +208.43(+1.74%) … Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock discussion in Yahoo … Discover historical prices for CPRX stock on Yahoo Finance. View daily, weekly or … Catalyst Pharmaceutical (CPRX) Dips More Than Broader Markets: What You … Find out all the key statistics for Catalyst Pharmaceuticals, Inc. (CPRX), including …
Cprx financials
Did you know?
WebApr 6, 2024 · CPRX Catalyst Pharmaceuticals, Inc. Financial Income Statement 17.73K followers $17.38 0.45 ( +2.66%) 4:00 PM 04/06/23 NASDAQ $USD Post-Market: … WebCPRX Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
WebGet the latest Catalyst Pharmaceuticals Inc (CPRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebFinancials: CPRX Edit my quotes Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours CPRX CPRX …
WebMar 17, 2024 · The Company is also focused on initiating clinical trials of amifampridine in other ultra-rare neuromuscular conditions. Price As of Thursday, March 16, Catalyst Pharmaceuticals Inc’s CPRX share price has surged by 9.83%, which has investors questioning if this is right time to sell. WebCatalyst Pharmaceuticals Inc. Quarterly stock financials by MarketWatch. View the latest CPRX financial statements, income statements and financial ratios.
WebApr 12, 2024 · In the latest trading session, Catalyst Pharmaceutical (CPRX) closed at $17.55, marking no change from the previous day. This move was narrower than the S&P 500's daily loss of 0.41%.
WebFinancials: CPRX Edit my quotes Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours … hasen hasenWebCPRX Finanicals Stock Screener Earnings Calendar Sectors Nasdaq CPRX U.S.: Nasdaq Catalyst Pharmaceuticals Inc. Watch list Create CPRX Alert After Hours Last Updated: Jan 23, 2024 5:49... book thumperWebCPRX: Rating increased to a BUY CATALYST PHARMACEUTICALS INC has an Investment Rating of BUY; a target price of $17.000000; an Industry Subrating of … hasenholzWebApr 6, 2024 · CPRX Stock Overview. About the company. Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine … hasenhof schrammelWebIn the latest trading session, Catalyst Pharmaceutical (CPRX) closed at $16.44, marking a +1.99% move from the previous day. Encompass Health (EHC) inaugurated the Owasso-based Ascension St. John Rehabilitation Hospital, that it will operate jointly with Ascension St. John to offer rehabilitative care in Oklahoma. has england ever won world cupWebMar 31, 2024 · Financial ratios and metrics for Catalyst Pharmaceuticals (CPRX). Includes annual, quarterly and trailing numbers with full history and charts. has england ever won the cricket world cupWebApr 14, 2024 · As of Dec 31, 2024, CPRX had cash, cash equivalents and investments worth $298.3 million compared with $256.1 million as of Sep 30, 2024. 2024 Results For the full year, the company reported... book throws